SEC Company Response from MEDICINOVA INC (MNOV) (CIK 0001226616) (MNOV) — Dec 14, 2009
MEDICINOVA INC (MNOV) (CIK 0001226616)
Date: Dec. 14, 2009 · CIK: 0001226616 · Accession: 0001193125-09-251980
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-163116
Letter
VIA EDGAR AND FACSIMILE Securities and Exchange Commission Attention: Jeffrey Riedler and Nandini Acharya Re: MediciNova, Inc. Registration Statement on Form S-3 (File No. 333-163116)
Dear Commissioners:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, MediciNova, Inc., a Delaware corporation (the “Company”), hereby respectfully requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-163116) so that such Registration Statement may be declared effective at 12:00 p.m. on December 16, 2009 or as soon as practicable thereafter.
We request that we be notified of such effectiveness by a telephone call to David E. Schulman of Dechert LLP at (202) 261-3440 and that such effectiveness also be confirmed in writing.
The Company hereby acknowledges that (i) should the Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing; (ii) the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for adequacy and accuracy of the disclosure in the filing; and (iii) the Company may not assert this action as defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Very truly yours,
MediciNova, Inc.
Show Raw Text
CORRESP 1 filename1.htm Acceleration Request MEDICINOVA, INC. 4350 LA JOLLA VILLAGE DRIVE, SUITE 950 SAN DIEGO, CA 92122 December 14, 2009 VIA EDGAR AND FACSIMILE Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Attention: Jeffrey Riedler and Nandini Acharya Re: MediciNova, Inc. Registration Statement on Form S-3 (File No. 333-163116) Dear Commissioners: Pursuant to Rule 461 under the Securities Act of 1933, as amended, MediciNova, Inc., a Delaware corporation (the “Company”), hereby respectfully requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-163116) so that such Registration Statement may be declared effective at 12:00 p.m. on December 16, 2009 or as soon as practicable thereafter. We request that we be notified of such effectiveness by a telephone call to David E. Schulman of Dechert LLP at (202) 261-3440 and that such effectiveness also be confirmed in writing. The Company hereby acknowledges that (i) should the Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing; (ii) the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for adequacy and accuracy of the disclosure in the filing; and (iii) the Company may not assert this action as defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. Very truly yours, MediciNova, Inc. By: /s/ Shintaro Asako Name: Shintaro Asako Title: Chief Financial Officer and Secretary